| David Andrew Wilkinson, MD | |
|
30 Hope Dr Ste 1200, Hershey, PA 17033-2036 | |
| (717) 531-3828 | |
| (717) 531-0793 |
| Full Name | David Andrew Wilkinson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 12 Years |
| Location | 30 Hope Dr Ste 1200, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740541994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD471040 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
News Archive
Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.
Recent developments have allowed ophthalmologic surgeons to move from transplanting the entire cornea in every patient to more focused operations that involve removing and replacing only the diseased or damaged portion of the cornea.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
University of Alberta research fellow Amy Speed-Andrews has examined how a specialized Iyengar yoga program for women currently in treatment for breast cancer, and who have completed treatment, makes a difference in their recovery.
› Verified 3 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.
Recent developments have allowed ophthalmologic surgeons to move from transplanting the entire cornea in every patient to more focused operations that involve removing and replacing only the diseased or damaged portion of the cornea.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
University of Alberta research fellow Amy Speed-Andrews has examined how a specialized Iyengar yoga program for women currently in treatment for breast cancer, and who have completed treatment, makes a difference in their recovery.
› Verified 3 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.
Recent developments have allowed ophthalmologic surgeons to move from transplanting the entire cornea in every patient to more focused operations that involve removing and replacing only the diseased or damaged portion of the cornea.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
University of Alberta research fellow Amy Speed-Andrews has examined how a specialized Iyengar yoga program for women currently in treatment for breast cancer, and who have completed treatment, makes a difference in their recovery.
› Verified 3 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.
Recent developments have allowed ophthalmologic surgeons to move from transplanting the entire cornea in every patient to more focused operations that involve removing and replacing only the diseased or damaged portion of the cornea.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
University of Alberta research fellow Amy Speed-Andrews has examined how a specialized Iyengar yoga program for women currently in treatment for breast cancer, and who have completed treatment, makes a difference in their recovery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Andrew Wilkinson, MD Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | David Andrew Wilkinson, MD 30 Hope Dr Ste 1200, Hershey, PA 17033-2036 Ph: (717) 531-3828 |
News Archive
Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.
Recent developments have allowed ophthalmologic surgeons to move from transplanting the entire cornea in every patient to more focused operations that involve removing and replacing only the diseased or damaged portion of the cornea.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
University of Alberta research fellow Amy Speed-Andrews has examined how a specialized Iyengar yoga program for women currently in treatment for breast cancer, and who have completed treatment, makes a difference in their recovery.
› Verified 3 days ago
Christopher Lowry Schaiberger, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Kimberly S Harbaugh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr Ste 1200, Hershey, PA 17033 Phone: 717-531-3828 Fax: 717-531-0793 | |
Haejoe Park, MD, MS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-0793 | |
Mark S Dias, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Steven J Schiff, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Dr. Michael David Sather, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr Ste 1200, Hershey, PA 17033 Phone: 717-531-3828 Fax: 717-531-0793 | |
Joseph Christopher Zacko, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr, Ec110, Hershey, PA 17033 Phone: 717-531-0895 Fax: 717-531-3858 |